Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Olfactory Dysfunction in Multiple Sclerosis: Evidence of a Decrease in Different Aspects of Olfactory Function.
Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo.
Comorbidity is associated with pain-related activity limitations in multiple sclerosis.
Bromodomains: translating the words of lysine acetylation into myelin injury and repair.
Long-distance effects of inflammation on differentiation of adult spinal cord neural stem/progenitor cells.
Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.
Walking Distance as a Predictor of Falls in People With Multiple Sclerosis.
Experimental autoimmune encephalomyelitis.
Determinants of disability in multiple sclerosis: an immunological and MRI study.
Systematic network lesioning reveals the core white matter scaffold of the human brain.
Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation.
Mosaic Subventricular Origins of Forebrain Oligodendrogenesis.
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis.
Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases.
Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up.
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
Antiretrovirals inhibit arginase in human microglia.
Microvesicles in the brain: Biomarker, messenger or mediator?
Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice.
Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis.
Changes in normal appearing spinal cord in multiple sclerosis: another brick in the wall.
Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region.
Factors Influencing Decision-making and Outcome in the Surgical Management of Trigeminal Neuralgia.
Pages
« first
‹ previous
…
657
658
659
660
661
662
663
664
665
…
next ›
last »